Ripretinib versus sunitinib in patients with advanced gastrointestinal stromal tumor after treatment with imatinib: a plain language summary of the phase 3 INTRIGUE trial

Future Oncology, Ahead of Print.

Source: Future Oncology - August 18, 2023 Category: Cancer & Oncology Authors: Marina Symcox Robin L Jones Source Type: research